• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用[3H]尼群地平标记的猪冠状动脉和主动脉中钙通道拮抗剂结合位点的特性研究

Characterization of calcium channel antagonist binding sites labeled by [3H]nitrendipine in porcine coronary artery and aorta.

作者信息

Yamada S, Harada Y, Nakayama K

机构信息

Department of Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka, Japan.

出版信息

Eur J Pharmacol. 1988 Sep 13;154(2):203-8. doi: 10.1016/0014-2999(88)90099-4.

DOI:10.1016/0014-2999(88)90099-4
PMID:2852598
Abstract

The receptor sites for dihydropyridine calcium channel antagonists in porcine coronary artery were characterized with [3H]nitrendipine (NTD), and were compared with those in the thoracic aorta. Specific [3H]NTD binding in the coronary artery and aorta was saturable, reversible and of high affinity. These sites showed a pharmacological specificity and stereoselectivity characteristic of the receptor sites for dihydropyridine calcium channel antagonists. The pharmacological potencies of nitrendipine, nifedipine, nisoldipine, (+)-PN 200-110 and (-)-PN 200-110 in the isolated porcine coronary artery correlated well with their potencies in competing for [3H]NTD binding sites. The Hill coefficients for the competition curves for these antagonists in the porcine coronary artery and aorta were close to one. Verapamil partially inhibited specific [3H]NTD binding in both tissues. The [3H]NTD binding was increased by Mg2+ and Ca2+ but was markedly reduced by EDTA. Thus, the present study has shown that [3H]NTD selectively labels the pharmacologically relevant dihydropyridine receptors in the porcine coronary artery and that there is no significant difference between the binding characteristics of the receptor sites in the coronary artery and aorta of pigs.

摘要

用[3H]尼群地平(NTD)对猪冠状动脉中二氢吡啶钙通道拮抗剂的受体位点进行了表征,并与胸主动脉中的受体位点进行了比较。冠状动脉和主动脉中特异性[3H]NTD结合具有饱和性、可逆性和高亲和力。这些位点表现出二氢吡啶钙通道拮抗剂受体位点的药理学特异性和立体选择性。尼群地平、硝苯地平、尼索地平、(+)-PN 200-110和(-)-PN 200-110在离体猪冠状动脉中的药理效力与其竞争[3H]NTD结合位点的效力密切相关。这些拮抗剂在猪冠状动脉和主动脉中的竞争曲线的希尔系数接近1。维拉帕米部分抑制了两种组织中特异性[3H]NTD结合。[3H]NTD结合因Mg2+和Ca2+而增加,但因EDTA而显著降低。因此,本研究表明,[3H]NTD选择性标记猪冠状动脉中与药理学相关的二氢吡啶受体,并且猪冠状动脉和主动脉中受体位点的结合特性之间没有显著差异。

相似文献

1
Characterization of calcium channel antagonist binding sites labeled by [3H]nitrendipine in porcine coronary artery and aorta.用[3H]尼群地平标记的猪冠状动脉和主动脉中钙通道拮抗剂结合位点的特性研究
Eur J Pharmacol. 1988 Sep 13;154(2):203-8. doi: 10.1016/0014-2999(88)90099-4.
2
Calcium channel receptor sites for (+)-[3H]PN 200-110 in coronary artery.冠状动脉中(+)-[3H]PN 200-110的钙通道受体位点。
J Pharmacol Exp Ther. 1990 Jan;252(1):327-32.
3
Characteristics of adrenoceptors and [3H]nitrendipine receptors of porcine vascular smooth muscle: differences between coronary artery and aorta.猪血管平滑肌肾上腺素能受体和[3H]尼群地平受体的特征:冠状动脉与主动脉之间的差异
Circ Res. 1987 Jun;60(6):837-44. doi: 10.1161/01.res.60.6.837.
4
Nitrendipine potentiates Bay k 8644-induced contraction of isolated porcine coronary artery: evidence for functionally distinct dihydropyridine receptor subtypes.尼群地平增强Bay k 8644诱导的离体猪冠状动脉收缩:功能不同的二氢吡啶受体亚型的证据。
Biochem Biophys Res Commun. 1985 May 16;128(3):1295-302. doi: 10.1016/0006-291x(85)91081-2.
5
Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.钙拮抗剂[3H]尼群地平与牛主动脉平滑肌和犬心肌膜中高亲和力位点的结合。
J Clin Invest. 1982 Jul;70(1):209-12. doi: 10.1172/jci110596.
6
Effect of neuraminidase on diltiazem-mediated alteration of nitrendipine binding in the hog coronary artery.神经氨酸酶对地尔硫䓬介导的猪冠状动脉中尼群地平结合改变的影响。
Jpn J Pharmacol. 1985 Oct;39(2):217-23. doi: 10.1254/jjp.39.217.
7
Identification of calcium antagonist receptor binding sites using (3H)nitrendipine in bovine tracheal smooth muscle membranes.
Experientia. 1984 Mar 15;40(3):267-9. doi: 10.1007/BF01947575.
8
Regulation of 1,4-dihydropyridine and beta-adrenergic receptor sites in coronary artery smooth muscle membranes.
Cell Signal. 1991;3(3):225-32. doi: 10.1016/0898-6568(91)90048-y.
9
NZ-105, a new 1,4-dihydropyridine derivative: correlation between dihydropyridine receptor binding and inhibition of calcium uptake in rabbit aorta.NZ-105,一种新型1,4-二氢吡啶衍生物:兔主动脉中二氢吡啶受体结合与钙摄取抑制之间的相关性
Jpn J Pharmacol. 1991 Nov;57(3):337-48. doi: 10.1254/jjp.57.337.
10
SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes.SR 33557,一种新型钙拮抗剂:与脑膜中[3H] -(±)-尼群地平及[3H] -(-)-去甲氧基维拉帕米结合位点的相互作用。
Naunyn Schmiedebergs Arch Pharmacol. 1989 Jan-Feb;339(1-2):31-6. doi: 10.1007/BF00165122.

引用本文的文献

1
Evidence for the presence of regional differences in the calcium antagonist receptors in lower urinary tract smooth muscle.下尿路平滑肌中钙拮抗剂受体存在区域差异的证据。
Naunyn Schmiedebergs Arch Pharmacol. 1992 Jun;345(6):679-87. doi: 10.1007/BF00164583.